Discovery is adhering to all pertinent guidance from the CDC and the WHO to keep our clients and employees safe while continuing to provide high quality, ethically obtained biospecimens to support COVID-19 diagnostic, vaccine, and therapeutic R&D programs.
Leveraging our global network of nearly 300 clinical sites (Discovery Partners®), we provide: